CN1048882C - Feiyanling medicine for curing infantile pneumonia - Google Patents

Feiyanling medicine for curing infantile pneumonia Download PDF

Info

Publication number
CN1048882C
CN1048882C CN94100361A CN94100361A CN1048882C CN 1048882 C CN1048882 C CN 1048882C CN 94100361 A CN94100361 A CN 94100361A CN 94100361 A CN94100361 A CN 94100361A CN 1048882 C CN1048882 C CN 1048882C
Authority
CN
China
Prior art keywords
medicine
radix
cough
root
pneumonia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94100361A
Other languages
Chinese (zh)
Other versions
CN1105570A (en
Inventor
李树丛
赵桂艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN94100361A priority Critical patent/CN1048882C/en
Publication of CN1105570A publication Critical patent/CN1105570A/en
Application granted granted Critical
Publication of CN1048882C publication Critical patent/CN1048882C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a medicine for treating infantile virus pneumonia, cold and other cough with dyspnea, which belongs to a Chinese patent medicine. The present invention comprises the components of the following compounding ratio: 4.0 to 21.7% of pilose asiabell root, 2.6 to 16.7% of white atractylodes rhizome, 4.6 to 17.2% of indigowoad root, 4.6 to 17.2% of indigowoad leaf, 2.5 to 12.1% of mulberry bark, 2.6 to 16.7% of wolfberry bark, 2.6 to 16.7% of apricot kernel, 2.6 to 16.7% of licorice root, 2.7 to 12.2% of common coltsfoot flower, 2.6 to 16.7% of stemona root, 2.6 to 11.4% of fresh ginger and 1.1 to 11.4% of round-shaped rice. After being weighed according to the percentage, the components can be made into syrup, medicinal granules, tablets, etc. by the procedures of soakage, decoction, etc. of the conventional pharmaceutical method.

Description

The pneumonia oral liquid
The present invention relates to a kind of pneumonia oral liquid for the treatment of viral pneumonia, also can be used for treatment flu and other coughs, it has syrup, electuary, tablet multiple, belongs to Chinese patent medicine.
The medicine of treatment infantile viral pneumonia is a lot of at present, but unsatisfactory curative effect, what have has a side effect, medicine such as antibiotics is invalid substantially to the primary disease treatment, though adrenal cortex boarding medicine can make remission, but immunity is further reduced, or untoward reaction such as rebound phenomenon, Ku Shizheng occur; The Chinese medicine of Ying Yonging is all with untoward reaction such as vomiting, abdominal distention, diarrhoea clinically.Fel Serpentis et Bulbus Fritillariae Cirrhosae Liquidus or children's cough syrup can only cough-relieving, and primary disease be there is no therapeutical effect.
The objective of the invention is to overcome the weak point in the background technology and provide a kind of for the treatment infantile viral pneumonia have the curative effect height, nontoxic, have no side effect, and can improve the pneumonia oral liquid of children's's immunocompetence.
The object of the present invention is achieved like this: it is the medicinal liquid of being made by the following raw materials by weight proportions thing: Radix Codonopsis 4.0-21.7%, Rhizoma Atractylodis Macrocephalae 2.6-16.7%, Radix Isatidis 4.6-17.2%, Folium Isatidis 4.6-17.2%, Cortex Mori 2.5-12.1%, Cortex Lycii 2.6-16.7%, Semen Armeniacae Amarum 2.6-16.7%, Radix Glycyrrhizae 2.6-16.7%, Flos Farfarae 2.7-12.2%, Radix Stemonae 2.6-16.7%, fresh ginger 2.6-11.4% and Semen oryzae sativae 1.1-11.4%, the above-mentioned medicine of respectively distinguishing the flavor of, by the prescription requirement, precentagewise is weighed, the method of more solito is made syrup, also can be made into electuary, tablet.The preferred weight proportioning of each medicine of distinguishing the flavor of is: Radix Codonopsis 11.2%, the Rhizoma Atractylodis Macrocephalae 7.4%, Radix Isatidis 11.1%, Folium Isatidis 11.1%, Cortex Mori 11.1%, Cortex Lycii 7.4%, Semen Armeniacae Amarum 7.4%, Radix Glycyrrhizae 7.4%, Flos Farfarae 11.1%, the Radix Stemonae 7.4%, fresh ginger 3.7% and Semen oryzae sativae 3.7%.
Pharmacology:
Radix Codonopsis: invigorating the spleen and replenishing QI, promote the production of body fluid and nourish blood, be mainly used in strengthening the body resistance;
The Rhizoma Atractylodis Macrocephalae: air making-up and spleen enlivening, dampness diuretic.Be used for transmitting and distributing the fluids, deficiency-weakness of spleen-QI promptly helps the power of Radix Codonopsis tonification, prevents cold and cool drug-induced diarrhoea again;
Radix Isatidis: have heat-clearing and toxic substances removing, the effect of removing heat from blood sore-throat relieving, modern pharmacological research has antivirus action;
Folium Isatidis: heat-clearing and toxic substances removing, antivirus action is arranged, with the same usefulness of Radix Isatidis, synergism is arranged;
Cortex Mori: eliminating pathogen from the lung for relieving asthma, inducing diuresis to remove edema;
Cortex Lycii: removing heat from blood moves back steaming, disappears to let out lung-heat, is used for deficiency of YIN heat in blood, the lung-heat cough with asthma;
Semen Armeniacae Amarum: relieving cough and asthma, loosening bowel to relieve constipation;
Radix Glycyrrhizae: invigorating the spleen and replenishing QI, nourishing the lung to arrest cough relaxes the property of medicine;
Flos Farfarae: nourishing the lung to keep the adverse QI downward, relieving cough and resolving phlegm is coughed principal agent for controlling, and strengthens the relieving cough and resolving phlegm effect of other drug:
The Radix Stemonae: nourishing the lung to arrest cough.For new chronic cough breathe heavily, multiple cough with asthma such as pertussis, lung impairment and cough is effective;
Rhizoma Zingiberis Recens: the cough-relieving panacea, vomit the back that can prevent to take medicine, and have the effect of warming the lung to relieve cough concurrently;
Semen oryzae sativae: stomach function regulating, messenger drug warm in nature and, in order to avoid because of the cold and cool gas that injures one's stomach.
Effect after each medicine of distinguishing the flavor of is synthetic: have strengthening the body resistance, heat-clearing and toxic substances removing, the effect of relieving cough and asthma, strengthening the body resistance is eliminating evil and usefulness with detoxifcation, heresy is dispelled and just do not hinder, just winning with anti-evil, multiple cough-relieving is breathed heavily flat, favourable disease recovery, assistant are removed the fraud of take medicine back vomiting, diarrhoea with the medicine of stomach function regulating preventing or arresting vomiting.
The present invention has following advantage compared to existing technology:
1, the used medicine of the present invention all is a pure natural medical, and is nontoxic lightly seasoned, and no special odor is fit to child administration;
2, curative effect height, short treating period, according to the treatment of 360 routine infants statistics, effective percentage 100%, cure rate 98%, and having no side effect is taken the no vomiting and diarrhoea phenomenon in back, and is harmless to liver, brain, the heart, kidney, no hormone-like effect, no rebound phenomenon, nothing allergy is reacted;
3, growth and the hemopoietic system to children's has no adverse effects, and has no adverse reaction with antibiotic and other drug combinations;
4, period in a medicine does not have taboo;
5, treating both the principal and secondary aspects of a disease, and can improve immunity in children.
Model case:
Example 1: high so-and-so: the woman, 2 years old, because of hyperpyrexia (39.5 ℃), cough with asthma was admitted to hospital in one day.Admission examination infant listlessness, die Blausucht, the anoxia symptom is obvious, and breathing is the devil, and breathes heavily and suppresses serious symptom, two lung percussions down are voiced sound, equal audible and thin moist gong sound, and abdomen is bloated slightly, and liver 2.5 horizontal fingers under rib can touch, matter is medium, heart rate 130 times 1 minute, numeration of leukocyte, sum 14.6 * 10 3/ l, neutrality 4.3%, lymph 67%, X line: two visible lamellar shades of lung down.Be diagnosed as viral pneumonia, give antibiotic, chlorpromazine, promethazine, Drug therapys such as dexamethasone were in hospital 13 days, the state of an illness increases the weight of, and heart failure occurs, through taking this medicine, the state of an illness transfers to steadily two days later, and patient's ordinary circumstance is good after 5 days, and the diet sleep is normal, temperature recovery is normal, and transference cure, auscultation of lung have a little wheezing sound, obeyed again 2 days, recovery from illness is left hospital.
Example 2, Liu so-and-so, the man, 12 years old, because of cough with asthma, dyspnea two days, admit to hospital admission examination with infantile pneumonia: 36.7 ℃ of body temperature, pulse 120 times/minute, die Blausucht, equal audible of two lungs and middle fine bubbling rale, abdomen is soft, and the liver spleen does not all touch, borborygmus normal presence, blood leukocytes counting, WBC9.6 * 10 3/ L, N37%, L63%, Chest X-rays Non Apparent Abnormality find, routine of western medicine treatment 15 days, the state of an illness increases the weight of repeatedly, and infant is breathed and is the devil, and breathe heavily to suppress and increase the weight of, cyanosis around oral region, the sample of nodding is breathed, heart rate 140 times/minute, infant listlessness, heart failure.Take this medicine after one day, cough with asthma is clearly better, since the cough with asthma improvement, the increase of ventilation, anoxia improves, and heart rate is reduced to 108 times/minute, with this medicine treatment one week recovery from illness.
Example 3, fourth so-and-so: the man, 8 months, cough with asthma, dyspnea, institute goes to a doctor over one day, the infant ordinary circumstance still can, two lung audibles and tiny bubble, routine blood test chemical examination, WBC7.5 * 10 9/ L, N31%, L69% is diagnosed as infantile pneumonia, gives anti-inflammatory treatment, and take cough suppressing medicine, treat 10 surplus day, the few effect, the state of an illness increases the weight of gradually, breathing is the devil, cyanosis around oral region, after please the traditional Chinese medical science open two doses in Chinese medicine oral (medicine and consumption are not quite clear), children's's inlet is promptly told, cry and scream, exempt from afterwards to gavage by force, but diarrhoea appearred in about 4 hours in the clothes back, two days later, the state of an illness does not have and is clearly better, and changes this medicine of clothes, drink-service again and again, and infant does not cry, do not tell, medication two days later, the state of an illness is steady, takes this medicine 9 days recovery from illness altogether.
Example 4, model so-and-so, the woman, 6 months, cough with asthma, dyspnea one day, the infant ordinary circumstance still can, lip cyanosis, two lung audibles and in fine bubbling rale, numeration of leukocyte, WBC8.2 * 10 9/ L, N56%, L44% is diagnosed as infantile pneumonia, does not do any treatment, takes we's recovery from illness after four days.
Consumption sees the following form:
Usage, each consumption (milliliter)
Age conventional amount used maximum minimum Usage
16 20 months-1 years old 3-7 18 3 1-1.5 of 2-3 month 0.5-3 10 0.5 3-5 month 1-4 12 1 5-7 month 1-5 14 1 1-10 month 2-6 year 3-8,20 3 1.5-2 year 4-9,25 4 2-3 year 5-10,30 5 3-5 year 5-15 10-15 50 10 more than 40 55 years old 4-6 time 1 day also can be a small amount of, repeatedly takes again and again.
Remarks: this prescription is nontoxic, excess does not have toxic reaction yet.
Below in conjunction with invention implement to be described in detail in detail: example 1: at first press Radix Codonopsis 11.2%, Radix Isatidis, Folium Isatidis, Cortex Mori, Flos Farfarae respectively 11.1%, the Rhizoma Atractylodis Macrocephalae, Cortex Lycii, Semen Armeniacae Amarum, Radix Glycyrrhizae, the Radix Stemonae each 1.4%, the percentage ratio of fresh ginger 3.3%, Semen oryzae sativae 3.7% is weighed and is prepared the back and soak and operation such as to decoct and promptly make syrup with conventional pharmaceutical methods, as: Radix Codonopsis, Radix Isatidis, Folium Isatidis, Cortex Mori, each 9g of Flos Farfarae, the Rhizoma Atractylodis Macrocephalae, Cortex Lycii, Semen Armeniacae Amarum, Radix Glycyrrhizae, each 6g of the Radix Stemonae, fresh ginger 3g, Semen oryzae sativae 3g make syrup 100ml.
Embodiment sees the following form:
Example 2 Example 3 Example 4 Example 5
Radix Codonopsis isatis root bighead atractylodes rhizome folium isatidis root bark of white mulberry root bark of Chinese wolf-berry almond Radix Glycyrrhizae tussilago tuber of stemona fresh ginger polished rice 3g 4% 9g 12% 6g 8% 9g 12% 9g 12% 6g 8% 6g 8% 6g 8% 9g 12% 6g 8% 3g 4% 3g 4% 20g 21.7% 9g 9.8% 6g 6.5% 9g 9.8% 9g 9.8% 6g 6.5% 6g 6.5% 6g 6.5% 9g 9.8% 6g 6.5% 3g 3.3% 3g 3.3% 9g 10.3% 15g 17.2% 6g 6.7% 9g 10.3% 9g 10.3% 6g 6.7% 6g 6.7% 6g 6.7% 9g 10.3% 6g 6.7% 3g 3.4% 3g 3.4% 9g 11.8% 4g 5.3% 6g 7.9% 9g 11.8% 9g 11.8% 6g 7.9% 6g 7.9% 6g 7.9% 9g 11.8% 6g 7.9% 3g 3.9% 3g 3.9%
Make syrup 100ml.Also can add the Radix Astragali, Poria among the we, Radix Codonopsis can replace with Radix Ginseng.

Claims (2)

1, a kind of pneumonia oral liquid, be that each flavor medicine is weighed in proportion through screening, pharmaceutical methods is routinely made syrup, it is characterized in that it is the medicinal liquid of being made by the following raw materials by weight proportions thing: Radix Codonopsis 4.0-21.7%, Rhizoma Atractylodis Macrocephalae 2.6-16.7%, Radix Isatidis 4.6-17.2%, Folium Isatidis 4.6-17.2%, Cortex Mori 2.5-12.1%, Cortex Lycii 2.6-16.7%, Semen Armeniacae Amarum 2.6-16.7%, Radix Glycyrrhizae 2.6-16.7%, Flos Farfarae 2.7-12.2%, Radix Stemonae 2.6-16.7%, fresh ginger 2.6-11.4% and Semen oryzae sativae 1.1-11.4%.
2, pneumonia oral liquid according to claim 1 is characterized in that the preferred weight proportioning of medicine is: Radix Codonopsis 11.2%, the Rhizoma Atractylodis Macrocephalae 7.4%, Radix Isatidis 11.1%, Folium Isatidis 11.1%, Cortex Mori 11.1%, Cortex Lycii 7.4%, Semen Armeniacae Amarum 7.4%, Radix Glycyrrhizae 7.4%, Flos Farfarae 11.1%, the Radix Stemonae 7.4%, fresh ginger 3.7% and Semen oryzae sativae 3.7%.
CN94100361A 1994-01-17 1994-01-17 Feiyanling medicine for curing infantile pneumonia Expired - Fee Related CN1048882C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN94100361A CN1048882C (en) 1994-01-17 1994-01-17 Feiyanling medicine for curing infantile pneumonia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN94100361A CN1048882C (en) 1994-01-17 1994-01-17 Feiyanling medicine for curing infantile pneumonia

Publications (2)

Publication Number Publication Date
CN1105570A CN1105570A (en) 1995-07-26
CN1048882C true CN1048882C (en) 2000-02-02

Family

ID=5029595

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94100361A Expired - Fee Related CN1048882C (en) 1994-01-17 1994-01-17 Feiyanling medicine for curing infantile pneumonia

Country Status (1)

Country Link
CN (1) CN1048882C (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1068740A (en) * 1991-07-13 1993-02-10 贾虎子 The compound method of pneumonia Xiaolingsan

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1068740A (en) * 1991-07-13 1993-02-10 贾虎子 The compound method of pneumonia Xiaolingsan

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
《中西医结合杂志》10(4) 1991.4.30 刘信善,清肺饮治疗婴幼儿肺炎45例 *
《四川中医》3(1) 1985.1.31 曹兴亚,大青叶,芦根,青蒿治疗肺部急性感染 *
《湖北中医杂志》(4) 1988.4.30 周继刚,泻白散临床运用举隅 *
《湖北中医杂志》(4) 1988.4.30 周继刚,泻白散临床运用举隅;《辽宁中医杂志》10(3) 1986.3.31 舟方泊,沙参麦冬汤加减治疗小儿迁延性肺炎25例;《四川中医》3(1) 1985.1.31 曹兴亚,大青叶,芦根,青蒿治疗肺部急性感染;《中西医结合杂志》10(4) 1991.4.30 刘信善,清肺饮治疗婴幼儿肺炎45例 *
《辽宁中医杂志》10(3) 1986.3.31 舟方泊,沙参麦冬汤加减治疗小儿迁延性肺炎25例 *

Also Published As

Publication number Publication date
CN1105570A (en) 1995-07-26

Similar Documents

Publication Publication Date Title
CN1136885C (en) Chinese medicine for treating dyspneic cough effectively
WO2021208335A1 (en) Traditional chinese medicine composition capable of removing toxins, dispelling dampness, and disinhibiting throat, and application thereof
CN1480189A (en) Medication for treating rhinitis
CN1201793C (en) Medicine composition for treatment of cough and asthma and preparation thereof
CN100579557C (en) Cough-stopping granule with honeysuckle flower and bulbus fritilariae
CN104940485A (en) Traditional Chinese medicine composition for treating infantile asthma and preparation method thereof
CN103705890A (en) Pharmaceutical composition with function of removing heat from lung to relieve cough
CN101278981B (en) Medicament for treating upper respiratory tract infection in children and preparation method thereof
CN110193061A (en) A kind of preparation and application of the Chinese herbal granules treating or preventing influenza virus of children infection
CN1048882C (en) Feiyanling medicine for curing infantile pneumonia
CN1440806A (en) Nasosinusitis treating Chinese medicine powder
CN101322733B (en) Chinese herbal medicine formulation for treating pollution lung disease
CN1069053C (en) Oral medicine for treating phlegm-heat cough
CN1872192A (en) A medication composition,and preparation method
CN102614322B (en) Medicinal composition for treating child asthmatic suffocating pneumonia
CN107158286B (en) Traditional Chinese medicine composition for treating respiratory tract injury induced symptoms caused by haze and preparation method thereof
CN105963501A (en) Method for preparing traditional Chinese medicine composition for treating infantile asthma
CN115089689B (en) Traditional Chinese medicine composition for treating spasmodic cough as well as preparation method and application thereof
CN1131062C (en) Trachitis treating Chinese medicine
CN1593587A (en) Lung nourishing and regulating pill for treating lung system diseases and preparation method thereof
CN101829213B (en) Medicine composition for treating asthma and preparation method thereof
CN108815438A (en) A kind of pharmaceutical composition for treating chronic obstructive pulmonary disease
CN102727614B (en) Chinese-western medicine preparation for treating chronic obstructive pulmonary disease
CN113491733A (en) Traditional Chinese medicine composition for treating infantile cough and asthma and application thereof
CN105168860A (en) Traditional Chinese medicine composite for treating infantile asthma and preparation method thereof

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee